About us WHO WE ARE

Aurore Life Sciences, established in 2017, is a leading manufacturer of Active Pharmaceutical Ingredients (APIs) and intermediates, offering high-quality, affordable bulk drug solutions to over 55 countries worldwide. With a pure-play focus on APIs and intermediates, Aurore is a fully backward-integrated pharmaceutical company dedicated to delivering to all regulated markets globally.

At the heart of our business model is complete backward integration, ensuring control over every stage of production—from raw materials to the final API. This streamlined process guarantees not only an uninterrupted supply chain but also enhances product consistency, quality, and cost-efficiency. By reducing our reliance on external suppliers, Aurore Life Sciences offers customers a reliable and uninterrupted supply of essential APIs and intermediates, positioning us as the preferred supplier of choice in the industry.

Our diverse product portfolio comprises over 60 APIs, more than 122 Drug Master Files (DMFs), and over 100 intermediates. Supported by state-of-the-art manufacturing facilities, we meet the evolving needs of pharmaceutical companies worldwide.

Aurore Life Sciences strictly adhering to cGMP guidelines. Our manufacturing units have undergone numerous inspections by regulatory bodies such as USFDA, HPRA, AGES, EMEA, EDQM, COFEPRIS, PMDA, TGA, WHO-Geneva, KFDA, ANVISA, and certifications like ISO 9001:2008 and OHSAS 18001:2007. This commitment to quality and compliance underscores our dedication to delivering safe, effective, and reliable pharmaceutical ingredients.

With cutting-edge facilities, a strong emphasis on innovation, and sustainability embedded in our core values, Aurore Life Sciences continues to earn its reputation for excellence in the industry. We remain committed to making essential medicines accessible globally while partnering with leading pharmaceutical companies to meet the healthcare needs of people worldwide.

We foster exclusivity and continued trust from our valued clientele by maintaining a high level of confidentiality and trust in technology transfers and product development.

Vision

Our vision is to become the most preferred global leader in API manufacturing by pushing the boundaries of innovation, sustainability, and quality.

Mission

At Aurore Life Sciences, our mission is to manufacture high-quality APIs that meet the unique needs of our clients and exceed their expectations. We accomplish this by developing innovative and sustainable solutions and investing in the best talent, technology, and processes. Our focus on delivering exceptional customer service and support builds long-term relationships with our clients while making a positive impact on society and the environment. Our commitment to excellence, transparency, and accountability drives us to continually improve and grow as a company. Join us in our mission to create a better tomorrow through pharmaceutical excellence.

Our Journey till now

  • 2017
    Founded with the establishment
    of our R&D Facility
  • 2018
    Acquired an API facility (Previously
    Mylan (Viatris)) located at Jeedimetla
  • 2019
    Our Greenfield site (Phase 1 ) in
    Hyderabad was initiated
  • 2020
    Production at Phase I site (Kazhipally) with ~200KL Capacity kicked off with the construction of Phase II beginning
  • 2021
    Our largest facility with 400KL capacity
    (Kazhipally) was made fully operational.
  • 2021
    Received WHO Geneva Approval at
    Jeedimetla site for Nirmatrelvir

Our Values

  • Ingenuity

    We foster a culture of resourcefulness, creativity, and problem-solving to develop innovative solutions to identify new opportunities and approaches to API manufacturing.

  • Reliability

    We deliver on our promises and commitments to our customers and stakeholders And operate with integrity, accountability, and transparency to earn the trust and loyalty of our partners

  • Collaboration

    We promote open communication, active listening, and constructive feedback to foster a collaborative work environment and build strong relationships with our partners and clients by working together to achieve common goals and mutual benefits.

  • Agility

    We embrace change and adaptability in a rapidly evolving industry and global marketplace prioritizing speed and efficiency in all aspects of our operations, from R&D to manufacturing to delivery